RecruitingNot ApplicableNCT06823089

Early Feasibility Study of Cartilage Defect Repair

Sponsor

Cytex Therapeutics, Inc.

Enrollment

15 participants

Start Date

Nov 6, 2025

Study Type

INTERVENTIONAL

Conditions

(Femoroacetabular Impingement)Hip Dysplasia Osteonecrosis Osteoarthritis, Hip Osteochondral Lesion Legg-Calvé-Perthes Disease

Summary

Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical intervention to treat.

Eligibility

Min Age: 14 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ReNew Hip Implant for people with (femoroacetabular impingement), hip dysplasia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years to 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEReNew Hip Implant

Surgical Intervention

Locations(1)

Washington University School of Medicine

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06823089

Related Trials

Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty: A Randomized Double-Blind Trial

NCT075814701 location

Study of Parameters of Osteosarcopenia in Patients With Hip Fracture

NCT047306221 location